QGEN
Price:
$46.16
Market Cap:
$10.24B
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, including kits and components for purification of nucleic acids from secondary sample materials; and instruments for nucleic acid purification and accessories. It also provides interferon-gamma release assay for TB testing, and assays for p...[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
1996-06-28
Stock Exchange
NYSE
Ticker
QGEN
According to Qiagen N.V.’s latest financial reports and current stock price. The company's current ROE is 2.59%. This represents a change of 372.04% compared to the average of 0.55% of the last 4 quarters.
The mean historical ROE of Qiagen N.V. over the last ten years is 6.03%. The current 2.59% ROE has changed -57.03% with respect to the historical average. Over the past ten years (40 quarters), QGEN's ROE was at its highest in in the December 2020 quarter at 8.57%. The ROE was at its lowest in in the September 2019 quarter at -6.51%.
Average
6.03%
Median
4.68%
Minimum
-1.63%
Maximum
16.55%
Discovering the peaks and valleys of Qiagen N.V. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 458.18%
Maximum Annual ROE = 16.55%
Minimum Annual Increase = -281.47%
Minimum Annual ROE = -1.63%
Year | ROE | Change |
---|---|---|
2023 | 8.96% | -26.58% |
2022 | 12.21% | -26.25% |
2021 | 16.55% | 458.18% |
2020 | 2.97% | -281.47% |
2019 | -1.63% | -122.62% |
2018 | 7.23% | 354.50% |
2017 | 1.59% | -48.45% |
2016 | 3.08% | -37.89% |
2015 | 4.97% | 12.80% |
2014 | 4.40% | 72.97% |
The current ROE of Qiagen N.V. (QGEN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
12.58%
5-year avg
7.81%
10-year avg
6.03%
Qiagen N.V.’s ROE is greater than Neogen Corporation (-0.75%), greater than Olink Holding AB (publ) (-7.07%), greater than Aclaris Therapeutics, Inc. (-26.28%), less than Syneos Health, Inc. (7.72%), less than IQVIA Holdings Inc. (21.50%), less than Medpace Holdings, Inc. (50.85%), less than ICON Public Limited Company (7.87%), less than Sotera Health Company (16.02%), greater than Akumin Inc. (-531.99%), greater than Genetron Holdings Limited (0%), greater than Natera, Inc. (-26.23%), greater than NeoGenomics, Inc. (-8.43%), greater than Guardant Health, Inc. (-1240.25%),
Company | ROE | Market cap |
---|---|---|
-0.75% | $2.75B | |
-7.07% | $3.24B | |
-26.28% | $252.87M | |
7.72% | $4.46B | |
21.50% | $36.49B | |
50.85% | $10.61B | |
7.87% | $17.52B | |
16.02% | $3.76B | |
-531.99% | $26.27M | |
0% | $127.29M | |
-26.23% | $22.06B | |
-8.43% | $2.33B | |
-1240.25% | $4.41B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Qiagen N.V. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Qiagen N.V. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Qiagen N.V.'s ROE?
How is the ROE calculated for Qiagen N.V. (QGEN)?
What is the highest ROE for Qiagen N.V. (QGEN)?
What is the 3-year average ROE for Qiagen N.V. (QGEN)?
What is the 5-year average ROE for Qiagen N.V. (QGEN)?
How does the current ROE for Qiagen N.V. (QGEN) compare to its historical average?